Harbor GTM brain

Harbor sells AI-assisted clinical trial data capture and trial execution to medical device, biotech and pharmaceutical sponsors.

category

AI clinical trial operations and EDC

market profile

  • text: Clinical trial sponsors buy both regulated execution services and electronic data capture, with study startup and data reconciliation as persistent operational bottlenecks.
  • text: Harbor is expanding from EDC software into full-service CRO delivery, while its public site still emphasizes software.

personas

  • title: Head of clinical operations at a device or biotech sponsor
    pains:
    • Slow EDC builds delay first patient and consume limited operations capacity.
    • Coordinating sites, monitoring and vendors creates a fragmented study timeline.
  • title: Clinical data manager or lead CRA
    pains:
    • Manual transcription and source verification compete with resolving meaningful data issues.
    • Delayed site entry makes it difficult to see study status in real time.
  • title: Investigator or academic research lead
    pains:
    • Grant budgets cannot easily absorb enterprise study software fees.
    • Small research teams need accessible tools without a long IT deployment.

icp

  • text: Small and growing medical device, biotech and pharmaceutical sponsors running regulated clinical studies, especially with lean clinical teams.
  • text: Academic hospitals, universities and investigator-initiated studies with limited software budgets are a distinct free-plan segment.
  • text: CROs and larger sponsors managing multiple trials can buy portfolio-oriented EDC with procurement and integration requirements.

message pillars

  • text: Start the database from the protocol rather than building every form manually.
  • text: Automate transcription while preserving a path back to source records.
  • text: Focus monitoring on the issues that matter to the study.

objections

  • objection: Can AI-generated study data be trusted for regulated research?
    response: Review traceability, audit trails, validation documentation and shared compliance responsibilities against the sponsor's SOPs before deployment.
  • objection: Will this work for a complex portfolio with established procurement?
    response: Evaluate its enterprise offering, SSO, integrations and master service agreement against the actual study requirements.
  • objection: Will an early-stage provider be able to execute an entire trial?
    response: Request references, delivery staffing and a study-specific operating plan; EDC proof alone does not establish full-service CRO capacity.

competitors

  • name: Medidata
    why: Established EDC alternative named in Harbor's comparison navigation.
  • name: Veeva
    why: Clinical data management platform competing for sponsor studies.
  • name: Medrio
    why: EDC vendor named in Harbor's comparison navigation.
  • name: REDCap
    why: Research data capture alternative particularly relevant to academic buyers.

influencers

  • name: Albert Cai
    url: https://www.linkedin.com/posts/ac-ai_from-the-outside-clinical-research-is-an-activity-7439367203184898049-TWPq
    why: Co-founder discussing the clinical research and EDC problem.

keywords

  • clinical trial EDC software
  • AI clinical data management
  • protocol to eCRF
  • clinical trial source data verification
  • medical device CRO
  • REDCap alternative
  • 21 CFR Part 11 EDC

voice

  • Practical and workflow-specific
  • Direct about legacy system friction
  • Compliance-conscious

signals

  • text: Sponsor announces a first-in-human or new device study and must build its trial database soon.
  • text: A CRO adds concurrent studies and seeks standardized data capture across its portfolio.
  • text: Research team is replacing REDCap or struggling with delayed manual entry.

stack

  • SSO / SAML
  • CTMS and eTMF integrations

pricing

model: freemium
starting price: Free for academic and nonprofit studies; commercial studies start at $2,000/month

motion

hybrid

channels

  • SEO
  • LinkedIn
  • founder-led sales
  • customer referrals

confidence

high

Founders

  • name: Albert Cai
    title: Founder/CEO
    role: CEO
    bio: Albert is the co-founder and CEO of Harbor. Before Harbor, Albert helped run clinical trials and regulatory strategy at Biolinq, helping take the company's first and flagship product from prototype through its first human studies and eventual FDA De Novo authorization. Albert studied biomedical engineering at the University of Michigan and attended boarding school at the Oklahoma School of Science and Mathematics.
  • name: Nathan H. Leung
    title: Founder/CTO
    role: CTO
    bio: Nate (CTO) is an ex-Google, ex-Ramp engineer who has built websites serving hundreds of thousands of visits per month and open-source projects with millions of downloads. He studied pure math at UCLA and computer science at the University of Michigan.

Back to YC companies